Trademark: 78963551
Status Date
Monday, October 25, 2010
Filing Date
Wednesday, August 30, 2006
Published for Opposition
Tuesday, July 3, 2007
Abandoned Date
Monday, October 25, 2010
5 Blood, blood derivatives, pharmaceuticals derived from recombinant DNA Technology all for medical use in the prevention and treatment of blood disorders; intravenous immunoglobulins for use in treatment of immunodeficiency disorders and in immune replacement therapy
Oct 25, 2010
Abandonment Notice Mailed - No Use Statement Filed
Oct 25, 2010
Abandonment - No Use Statement Filed
Mar 30, 2010
Notice Of Approval Of Extension Request E-Mailed
Mar 29, 2010
Extension 5 Granted
Mar 25, 2010
Extension 5 Filed
Mar 25, 2010
Teas Extension Received
Sep 8, 2009
Extension 4 Granted
Sep 3, 2009
Extension 4 Filed
Sep 3, 2009
Teas Extension Received
Mar 3, 2009
Extension 3 Granted
Feb 27, 2009
Extension 3 Filed
Feb 27, 2009
Teas Extension Received
Sep 10, 2008
Extension 2 Granted
Sep 2, 2008
Extension 2 Filed
Sep 10, 2008
Case Assigned To Intent To Use Paralegal
Sep 2, 2008
Teas Extension Received
Jan 24, 2008
Extension 1 Granted
Jan 24, 2008
Extension 1 Filed
Jan 24, 2008
Teas Extension Received
Nov 7, 2007
Notice Of Allowance Correction Entered
Sep 25, 2007
Noa Mailed - Sou Required From Applicant
Jul 3, 2007
Published For Opposition
Jun 13, 2007
Notice Of Publication
May 30, 2007
Assignment Of Ownership Not Updated Automatically
May 30, 2007
Law Office Publication Review Completed
May 30, 2007
Assigned To Lie
May 11, 2007
Approved For Pub - Principal Register
May 11, 2007
Amendment From Applicant Entered
Apr 23, 2007
Correspondence Received In Law Office
Apr 23, 2007
Paper Received
Jan 25, 2007
Non-Final Action E-Mailed
Jan 25, 2007
Non-Final Action Written
Jan 24, 2007
Assigned To Examiner
Oct 4, 2006
Applicant/Correspondence Changes (Non-Responsive) Entered
Sep 26, 2006
Paper Received
Sep 6, 2006
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
